{"slug":"india","tag":"india","variants":["india"],"description":"No description yet","count":3,"kinds":{"trial":3},"related":[],"records":[{"id":"polcagb","kind":"trial","name":"POLCAGB","route":"/trials/polcagb/","status":"active","tldr":"In Mumbai, where gallbladder cancer is common, POLCAGB randomised patients with locally advanced but non-metastatic gallbladder cancer to chemotherapy or chemoradiotherapy before surgery. It is the largest randomised trial in gallbladder cancer alone and finished recruiting 124 patients in 2025."},{"id":"neogb","kind":"trial","name":"NEOGB","route":"/trials/neogb/","status":"recruiting","tldr":"NEOGB is an Indian phase 3 trial testing whether chemotherapy before surgery improves three-year survival in gallbladder cancer that is still removable but locally advanced. It opened in January 2025 and plans 114 patients."},{"id":"rugb","kind":"trial","name":"RUGB","route":"/trials/rugb/","status":"recruiting","tldr":"RUGB asks whether adding radiotherapy to chemotherapy helps people whose gallbladder cancer cannot be removed but has not spread. It is a 249-patient randomised trial in India, the only phase 2/3 test of radiotherapy in gallbladder cancer alone."}]}